Clincosm LogoSign in Get a demo

leukemia, myelogenous, acute

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of

Completed
  • Leukemia, Myelogenous, Acute
    • Charlotte, North Carolina
      Levine Cancer Institute
    Apr 19, 2022

    Minimal Residual Disease, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Charlotte, Seattle (Clofarabine,

    Terminated
    Has Results
    • Minimal Residual Disease
    • +2 more
    • Charlotte, North Carolina
    • +1 more
    Oct 4, 2021

    Leukemia, Myelogenous, Acute Trial in Minneapolis (biological, drug, procedure)

    Terminated
    Has Results
    • Leukemia, Myelogenous, Acute
    • Natural Killer Cells
    • +5 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Dec 3, 2017

    Leukemia, Myelogenous, Acute, MDS Trial in Gainesville (OXi4503)

    Terminated
    • Leukemia, Myelogenous, Acute
    • Myelodysplastic Syndromes
    • Gainesville, Florida
      UF Health Shands Cancer Hopsital
    Aug 7, 2017

    Leukemia, Myelogenous, Chronic, Leukemia, Lymphoblastic, Acute, Leukemia, Myelogenous, Acute Trial in Chicago (drug, other,

    Unknown status
    • Leukemia, Myelogenous, Chronic
    • +4 more
    • Myeloablative Chemotherapy Regimen for Lymphoid Malignancies or Cord Blood Unit Recipients
    • +3 more
    • Chicago, Illinois
      Children's Memorial Hospital
    Mar 29, 2011